After being fired, I became the light of medicine

Chapter 51: See the situation clearly! (Please read on!)
"Fake! This is definitely fake!"

As soon as the news came out, the entire domestic pharmaceutical industry was shaken, and everyone’s first reaction was that “ITG”’s clinical data was falsified!

After all, falsification of clinical data is not uncommon both at home and abroad!
but,

After calming down a little, everyone realized one thing:
If the clinical data is falsified, why not set the cure rate at 90%!

In this way, not only is it more credible, but the remaining 10% probability can also be used as an excuse and rhetoric!
And now,
Tsingshan Pharmaceutical directly announced the clinical data showing 100% clinical cure, which undoubtedly put itself in the spotlight and cut off its own retreat!

So!

There is only one truth!
That is, the Phase III clinical trial data released by Tsingshan Pharmaceutical is true!
"ITG human myelopoietin" can really cure aplastic anemia 100% completely!

hiss!
Major pharmaceutical companies were shocked.

They have begun to realize that the treatment plan for "aplastic anemia" in China and even the world is likely to change!

I am afraid that the first-line drugs for the treatment of aplastic anemia, such as eltrombopag and avatrombopag, will be seriously affected!
Suddenly.

Everyone thought of AkaRx, a company that competed fiercely with Tsingshan Pharmaceutical some time ago!

“I thought AkaRx was a rock, but I didn’t expect it to be a rock!”

In the office of Hengrui Medicine in Jiangsu Province.

General Manager Su Lin looked unhappy and was also aware of this problem.

A few months ago, he thought that Tsingshan Pharmaceutical would be caught in a painful competition with AkaRx, but he did not expect that just a few months later, Tsingshan Pharmaceutical would be able to break through the siege and even completely change the treatment plan for one of the three major blood diseases - aplastic anemia!

Such R&D capabilities are truly terrifying.

"Wenping, besides 'ITG epoxin', does Qingshan Pharmaceutical have any other new drugs in clinical trials now?"

"Boss Su, as far as I know, there isn't one yet!"

"call…!"

Su Lin exhaled lightly.

Fortunately, although Tsingshan Pharmaceutical is strong, the drugs it develops do not currently overlap with Hengrui's drugs. This is the best news.

"Wen Ping, you should pay special attention to their movements from now on. This Qingshan Pharmaceutical Company should not be underestimated!"

"AkaRx will never be able to stop Qingshan Pharmaceutical again!"

"At this time, I'm afraid they are all exhausted!"

……

Su Lin was right. At this moment,
In the headquarters building of Shanghai Fuxing Pharmaceutical, Mike, the vice president of AkaRx, was roaring wildly in his office!

"Impossible! There is no way they can develop a drug that can cure 'Aplastic Anemia'!"

"We have invested so much research and development funds over the years and have devoted so many scientific research resources to still not find the right compound. How could they possibly develop it?!"

"Fake! Absolutely fake!"

Gao Qiang, a senior executive of Fuxing Pharmaceutical, stood aside and watched quietly. He seemed much calmer.

When the voice died down, he shook his head:

"Mike, there's no reason for them to fake it."

"With so many patients participating in the Phase III clinical trial in person, it is impossible to fake it. It makes no sense for them to fake it!"

"I think we have to change our strategy!"

"Change of strategy?"

Mike's face turned gloomy. Although he was one of the people in the company who was unwilling to withdraw from the Chinese market, at this moment the price of the company's "Avatrombopag" had dropped to 3000 yuan!
Still going down?!

"No, it's impossible!"

"The price of our Avatrombopag has dropped from 7800 yuan to 3000 yuan, which is the lowest price in any market around the world!"

"We can't possibly descend any further!"

As he spoke, he suddenly grabbed Gao Qiang:
"Gao, didn't you say before that your Fuxing Pharmaceutical has a wide network of contacts in China and a lot of resources, and can completely prevent them from entering the hospital channel?"

"Besides, you have done a great job in the past few months. They can't get into any large, well-known tertiary hospitals except for some small ones!" "We can continue with this strategy!"

Gao Qiang was silent for a moment, then looked at Mike and shook his head again:

"President Mike, things are different now. Think carefully. Once their 'ITG human myelopoietin' is on the market, will our strategy still be effective?"

"Not anymore!"

"All patients with aplastic anemia will give priority to their ITG anabolic steroids. And those tertiary hospitals, especially the top tertiary hospitals, dare not purchase Qingshan Pharmaceutical's ITG? They dare not!"

"No procurement means no best treatment plan. Without the best treatment plan, there will be no patients! Without patients, there will be no income!"

"Although we have a good relationship, everything is nothing when it comes to interests!"

He paused and said in a calmer tone:

"Mike, face reality!"

"Qingshan Pharmaceutical has developed an exclusive drug called 'ITG Genotropin'. We are simply unable to compete, so... we must change our strategy!"

After he finished speaking, Mike slumped heavily in his chair, and Gao Qiang's words about "exclusive medicine" kept echoing in his ears!
More than a year ago,
The company’s own “Avatrombopag” is such an exclusive drug.

He still remembered that even though it was sold at 7000 yuan at that time, the top hospitals in China were still scrambling and begging to buy it!

And now!
The exclusive drug became... Qingshan Pharmaceutical!
Offensive and defensive changes!

……

Facts soon proved Gao Qiang's judgment was correct. The day after Qingshan Pharmaceutical officially announced the 100% cure rate of the Phase III clinical trial, even the last few patients who were waiting and watching could no longer sit still.

Chengdu Third People's Hospital.

"Sister, please make an appointment for me. I want to see Director Hu of the Hematology Department."

"Director Hu's is gone."

"What about the other doctors?"

“The other doctors’ are gone too.”

The patient who came from afar suddenly became anxious.

"Sister, can you please help me add a number? We came here from another place just to make an appointment..."

"Hey!" The lady at the registration window gave me a look of pity.

"We can't add an appointment here. Please go to the outpatient nurse station and ask."

……

"Sister nurse, they said there are no more appointments available. Could you please help me get a number for Director Hu? We came all the way from another city..."

"Register first. I can only ask Director Hu if you can still add me."

"thanks, thanks!"

……

"Director Hu... there's another patient coming from out of town. Can you add another patient?"

Director Hu: “…”

"I really can't add any more. I've already added 30 numbers! Can you go ask Teacher Ren if they can still add more?"

Teacher Ren:

"Hey, Director Hu, do you still want me to eat? Do you still want me to get off work? Do you still want me to rest?"

……

This is the most realistic situation in the Hematology Department of Chengdu Third People's Hospital in recent days.

Director Hu and all the outpatient doctors are both happy and sad, because all patients know that this is the hospital with the most experience in using "ITG" in the country, and also the hospital with the most experience in curing "aplastic anemia"!

Although "ITG human myelopoietin" has not yet been put on the market for sale, everyone can't wait to build files and do inspections in advance, waiting for Qingshan Pharmaceutical's "ITG human myelopoietin" to be put on the market!

(End of this chapter)